ONCOLYTICS BIOTECH INC/ CA6823108759 /
| 2024-05-14 6:58:20 PM | Chg. 0.00 | Volume | Bid7:19:51 PM | Ask7:19:51 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.60CAD | 0.00% | 7,335 Turnover: 11,647 |
1.60Bid Size: 25,300 | 1.61Ask Size: 100 | 1.63 | 1.60 |
Newsfile Corp
03-06
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
GlobeNewswire
03-05
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
Newsfile Corp
02-15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
02-14
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire
01-09
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
2018-12-12
Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and t...
GlobeNewswire
2018-12-03
Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasom...
GlobeNewswire
2018-11-29
Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer
GlobeNewswire
2018-11-26
Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytru...
GlobeNewswire
2018-11-12
Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2018-11-09
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Me...
GlobeNewswire
2018-11-05
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporat...
GlobeNewswire
2018-11-01
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep ...
GlobeNewswire
2018-10-22
Oncolytics Biotech® Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS M...
GlobeNewswire
2018-10-11
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract f...
GlobeNewswire
2018-10-02
Oncolytics Biotech® Announces a Publication Demonstrating That Intravenously Delivered Oncolytic Vir...
GlobeNewswire
2018-09-28
Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln...
GlobeNewswire
2018-09-26
Oncolytics Biotech® to Present at the Ladenburg Thalmann 2018 Healthcare Conference
GlobeNewswire
2018-09-17
Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and ...
GlobeNewswire
2018-09-10
Oncolytics Biotech® Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cance...
GlobeNewswire
2018-09-06
Oncolytics Biotech® Announces a Master Clinical Supply Agreement of an Anti-PD-L1 Checkpoint Inhibit...
GlobeNewswire
2018-07-31
Oncolytics Biotech® to Present at the Canaccord Genuity 38th Annual Growth Conference
